Skip to main content
Year archive

Leadway Technology Investment Group Limited — 2022 filings

All 95 regulatory filings released by Leadway Technology Investment Group Limited (2086) in 2022, sourced directly from the official regulator.

95 Filings
2022 Period
2022 filings (95)
Filing Released Lang
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE
Governance Information
2022-12-30 English
TERMS OF REFERENCE FOR THE REMUNERATION COMMITTEE
Remuneration Information
2022-12-30 English
TERMS OF REFERENCE FOR THE AUDIT COMMITTEE
Governance Information
2022-12-30 English
Poll Result of the Extraordinary General Meeting held on 21 December 2022
Declaration of Voting Results & Voting Rights Announcements
2022-12-21 English
Disposal of Properties and Ancillary Equipment held by Tianjin Biochemical Pharmaceutical Co., Ltd.
Capital/Financing Update
2022-12-13 English
Announcement Pursuant to Rule 13.18 of the Listing Rules
Capital/Financing Update
2022-12-07 English
Announcement Pursuant to Rule 13.18 of the Listing Rules
Capital/Financing Update
2022-12-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022
Regulatory Filings
2022-12-01 English
Notice of Extraordinary General Meeting
AGM Information
2022-11-29 English
Form of Proxy for Extraordinary General Meeting to be held on 21 December 2022
Proxy Solicitation & Information Statement
2022-11-29 English
Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement and Notice of Extraordinary General Meeting
Regulatory Filings
2022-11-29 English
Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement and Notice of Extraordinary General Meeting
Proxy Solicitation & Information Statement
2022-11-29 English
Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement
Regulatory Filings
2022-11-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022
Regulatory Filings
2022-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-01 English
Unaudited Financial Results for the nine months ended 30 September 2022 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report 9M 2022
2022-10-27 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2022
Regulatory Filings
2022-10-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-05 English
2022 Interim Report
Interim / Quarterly Report H1 2022
2022-09-15 English
Interim Report 2022
Interim / Quarterly Report H1 2022
2022-09-09 English
Interim Dividend for the six months ended 30 June 2022 (Revised)
Notice of Dividend Amount
2022-09-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022
Regulatory Filings
2022-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-01 English
Interim Dividend for the six months ended 30 June 2022
Notice of Dividend Amount
2022-08-30 English
Announcement of Interim Results for the six months ended 30 June 2022
Interim / Quarterly Report H1 2022
2022-08-30 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
Interim / Quarterly Report H1 2022
2022-08-25 English
Unaudited Financial Results for the six months ended 30 June 2022 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report H1 2022
2022-08-25 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
Interim / Quarterly Report H1 2022
2022-08-24 English
Date of Board Meeting
Regulatory Filings
2022-08-17 English
Change of Address of Share Registrar and Transfer Office
Regulatory Filings
2022-08-15 English
POSITIVE PROFIT ALERT
Regulatory Filings
2022-08-12 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-08-10 English
Discloseable Transaction - Subscriptions of Wealth Management Products
Capital/Financing Update
2022-08-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022
Regulatory Filings
2022-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-01 English
(1) CHANGE OF COMPANY NAME&#x3b; (2) CHANGE OF STOCK SHORT NAMES&#x3b; (3) CHANGE OF COMPANY WEBSITE ADDRESS&#x3b; (4) CHANGE OF COMPANY LOGO&#x3b; AND (5) CHANGE OF TELEPHONE AND FACSIMILE NUMBERS
Regulatory Filings
2022-07-08 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2022-07-05 English
CHANGE OF DIRECTOR
Board/Management Information
2022-07-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022
Regulatory Filings
2022-07-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-04 English
Potential Disposal of Properties and Ancillary Equipment held by Tianjin Biochemical Pharmaceutical Co., Ltd.
Capital/Financing Update
2022-06-30 English
Poll Results of the Annual General Meeting held on 23 June 2022
Declaration of Voting Results & Voting Rights Announcements
2022-06-23 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2022
Share Issue/Capital Change
2022-06-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-01 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 24 MAY 2022
Declaration of Voting Results & Voting Rights Announcements
2022-05-24 English
Notice of Annual General Meeting
AGM Information
2022-05-19 English
Form of Proxy for Annual General Meeting to be held on 23 June 2022
AGM Information
2022-05-19 English
General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors and Notice of Annual General Meeting
AGM Information
2022-05-19 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2022
Regulatory Filings
2022-05-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-03 English
Annual Report 2021
Annual Report FY 2021
2022-04-27 English
Unaudited Financial Results for the three months ended 31 March 2022 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report Q1 2022
2022-04-27 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (or at any adjournment thereof)
AGM Information
2022-04-20 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF THE RETIRING DIRECTORS AND PROPOSED CHANGE OF COMPANY NAME AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2022-04-20 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2022-04-20 English
Annual Report 2021
Annual Report FY 2021
2022-04-20 English
ANNOUNCEMENT RESTORATION OF PUBLIC FLOAT
Major Shareholding Notification
2022-04-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022
Regulatory Filings
2022-04-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-01 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2022-03-30 English
SUPPLEMENTAL ANNOUNCEMENT ON APPOINTMENT OF DIRECTORS AND CHANGE OF COMPOSITION OF THE BOARD COMMITTEES
Board/Management Information
2022-03-30 English
PROPOSED CHANGE OF COMPANY NAME
Board/Management Information
2022-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
Annual Report FY 2021
2022-03-30 English
Final Dividend for the year ended 31 December 2021
Notice of Dividend Amount
2022-03-30 English
Announcement of Final Results for the year ended 31 December 2021
Annual Report FY 2021
2022-03-30 English
Audited Financial Results for the year ended 31 December 2021 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Annual Report FY 2021
2022-03-25 English
Date of Board Meeting
Regulatory Filings
2022-03-18 English
Positive Profit Alert
Earnings Release FY 2021
2022-03-11 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2022-03-07 English
APPOINTMENT OF DIRECTORS AND RE-DESIGNATION OF DIRECTOR
Board/Management Information
2022-03-07 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-03-07 English
GRANT OF WAIVER FROM STRICT COMPLIANCE WITH THE MINIMUM PUBLIC FLOAT REQUIREMENT
Regulatory Filings
2022-03-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2022
Major Shareholding Notification
2022-03-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-01 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2022-02-28 English
RESIGNATION OF DIRECTORS&#x3b; CHANGE OF CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER&#x3b; AND CHANGE OF COMPOSITION OF THE BOARD COMMITTEES
Board/Management Information
2022-02-28 English
Overseas Regulatory Announcement
Earnings Release FY 2021
2022-02-25 English
JOINT ANNOUNCEMENT (1) CLOSE OF MANDATORY UNCONDITIONAL CASH OFFER BY HOORAY SECURITIES LIMITED ON BEHALF OF THE JOINT OFFERORS TO ACQUIRE ALL THE ISSUED SHARES OF HNA TECHNOLOGY INVESTMENTS HOLDINGS
M&A Activity
2022-02-25 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022
Regulatory Filings
2022-02-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-07 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2022-02-04 English
JOINT ANNOUNCEMENT (1) DESPATCH OF COMPOSITE DOCUMENT RELATING TO MANDATORY UNCONDITIONAL CASH OFFER BY HOORAY SECURITIES LIMITED ON BEHALF OF THE JOINT OFFERORS TO ACQUIRE ALL THE ISSUED SHARES OF HN
M&A Activity
2022-02-04 English
Documents on Display
M&A Activity
2022-02-04 English
FORM OF ACCEPTANCE AND TRANSFER OF ORDINARY SHARES OF HK$0.10 EACH IN THE ISSUED SHARE CAPITAL OF HNA TECHNOLOGY INVESTMENTS HOLDINGS LIMITED
Merger & Acquisition
2022-02-04 English
COMPOSITE DOCUMENT RELATING TO MANDATORY UNCONDITIONAL CASH OFFER BY HOORAY SECURITIES LIMITED ON BEHALF OF THE JOINT OFFERORS TO ACQUIRE ALL THE ISSUED SHARES OF HNA TECHNOLOGY INVESTMENTS HOLDINGS L
M&A Activity
2022-02-04 English
Overseas Regulatory Announcement
Interim / Quarterly Report FY 2021
2022-01-23 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings
2022-01-13 English
JOINT ANNOUNCEMENT (1) AGREEMENT IN RELATION TO THE SALE AND PURCHASE OF SHARES IN HNA ECOTECH PIONEER ACQUISITION&#x3b; (2) MANDATORY UNCONDITIONAL CASH OFFER BY HOORAY SECURITIES LIMITED ON BEHALF O
M&A Activity
2022-01-12 English
TRADING HALT
Regulatory Filings
2022-01-12 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings
2022-01-12 English
List of Directors and their Roles and Functions
Governance Information
2022-01-07 English
Change of Chairman and Executive Director, Authorised Representative and Change in Composition of Nomination Committee, Remuneration Committee and Investment Committee
Board/Management Information
2022-01-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021
Regulatory Filings
2022-01-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-03 English